RESUMEN
Health leaders are faced with a lack of public trust in healthcare governance. This waning trust relationship was further solidified through the pandemic. Improving the relationship between health organizations and the community/citizens/patient partners is a moral imperative of which ethical governance is a significant factor. This article will structure the ethical analysis of patient partners in governance through reviewing who we are, how we function, and what we do on governance boards. Taking an ethical approach will enable the promise of the value and impact of the patient partner to be actualized. Ethical governance that recognizes the significant contributions and value of engaged patient partners can be achieved and may be one of the significant levers required to transform healthcare.
Asunto(s)
Participación del Paciente , Humanos , Confianza , Consejo Directivo/ética , Consejo Directivo/organización & administración , Atención a la Salud/ética , Atención a la Salud/organización & administraciónRESUMEN
This Viewpoint describes the failure of yet another state institution to generate meaningful guidance about medical exceptions to abortion bans.
Asunto(s)
Aborto Legal , Atención a la Salud , Consejo Directivo , Servicios de Salud Materna , Complicaciones del Embarazo , Femenino , Humanos , Embarazo , Aborto Inducido/ética , Aborto Inducido/legislación & jurisprudencia , Aborto Legal/ética , Aborto Legal/legislación & jurisprudencia , Inutilidad Médica/legislación & jurisprudencia , Inutilidad Médica/ética , Texas/epidemiología , Consejo Directivo/ética , Consejo Directivo/legislación & jurisprudencia , Mortalidad Materna , Servicios de Salud Materna/ética , Servicios de Salud Materna/legislación & jurisprudencia , Servicios de Salud Materna/normas , Complicaciones del Embarazo/mortalidad , Complicaciones del Embarazo/cirugía , Atención a la Salud/ética , Atención a la Salud/legislación & jurisprudencia , Atención a la Salud/normas , Calidad de la Atención de Salud/ética , Calidad de la Atención de Salud/legislación & jurisprudencia , Calidad de la Atención de Salud/normasRESUMEN
INTRODUCTION: Our goal in this study was to determine female representation on editorial boards of high-ranking emergency medicine (EM) journals. In addition, we examined factors associated with gender disparity, including board members' academic rank, departmental leadership position, h-index, total publications, total citations, and total publishing years. METHODS: In this retrospective study, we examined EM editorial boards with an impact factor of 1 or greater according to the Clarivate Journal Citations Report for a total of 16 journals. All board members with a doctor of medicine or doctor of osteopathic medicine degree, or international equivalent were included, resulting in 781 included board members. We analyzed board members' gender, academic rank, departmental leadership position, h-index, total publications, total citations, and total publishing years. RESULTS: Gender disparity was clearly notable, with men holding 87.3% (682/781) of physician editorial board positions and women holding 12.7% (99/781) of positions. Only 6.6% (1/15) of included editorial board chiefs were women. Male editorial board members possessed higher h-indices, total citations, and more publishing years than their female counterparts. Male board members held a greater number of departmental leadership positions, as well as higher academic ranks. CONCLUSION: Significant gender disparity exists on EM editorial boards. Substantial inequalities between men and women board members exist in both the academic and departmental realms. Addressing these inequalities will likely be an integral part of achieving gender parity on editorial boards.
Asunto(s)
Medicina de Emergencia , Consejo Directivo , Publicaciones Periódicas como Asunto/estadística & datos numéricos , Edición , Éxito Académico , Políticas Editoriales , Femenino , Equidad de Género , Consejo Directivo/ética , Consejo Directivo/organización & administración , Consejo Directivo/estadística & datos numéricos , Humanos , Relaciones Interpersonales , Factor de Impacto de la Revista , Liderazgo , Masculino , Edición/ética , Edición/organización & administración , Edición/normas , Estudios RetrospectivosRESUMEN
INTRODUCTION: To address ethical concerns about the of future research authorization, biobanks employing a broad model of consent can design ongoing communication with contributors. Notifying contributors at the time of sample distribution provides one form of communication to supplement broad consent. However, little is known about how community-informed governance might anticipate contributor responses and inform communication efforts. OBJECTIVE: We explored the attitudes of members of a three-site Community Advisory Board (CAB) network. CAB members responded to a hypothetical proposal for notifying biobank contributors at the time of sample distribution to researchers utilizing the biobank. METHODS: We used regularly scheduled CAB meetings to facilitate 3 large-group and 6 small-group discussions. Discussions were audio-recorded, transcribed, and analyzed for thematic content using descriptive thematic analysis. RESULTS: The results challenged our expectation of general support for the proposed communications. While CAB members identified some advantages, they were concerned about several potential harms to biobank contributors and the biobank. The CABs understood biobank communication in terms of an ongoing relationship with the biobank and a personal contribution to research. CONCLUSION: Our findings contribute to the emerging literature on community engagement in biobanking. Additional communication with biobank contributors can serve a variety of value-based objectives to supplement broad consent. Design of communication efforts by biobanks can be improved by CAB members' anticipation of the unintended consequences of additional contact with contributors. CAB members' holistic interpretation of communication efforts suggests that biobank leadership considers all communication options as part of a more comprehensive communications strategy.
Asunto(s)
Bancos de Muestras Biológicas , Comunicación , Consejo Directivo , Consentimiento Informado , Acceso a la Información , Actitud , Bancos de Muestras Biológicas/ética , Bancos de Muestras Biológicas/tendencias , Ética en Investigación , Consejo Directivo/ética , Consejo Directivo/organización & administración , Humanos , Consentimiento Informado/ética , Consentimiento Informado/normas , Derechos del PacienteRESUMEN
BACKGROUND: In 2018, a so-called crisis developed in the international network of systematic reviewers known as Cochrane. It was widely depicted in terms of two competing narratives-"bad behaviour" by one member of Cochrane's Governing Board and scientific and moral decline within Cochrane. OBJECTIVE: Our goal was to distil insights on the structural issues underpinning the crisis, without taking a definitive position on the accuracy of either narrative. APPROACH AND DATASET: In this paper, we draw on (among other theories) Becker's notion of moral entrepreneurship and Foucault's conceptualisation of power to analyse the claims and counterclaims made by different parties. Our dataset consisted of publicly available materials (blogs, journal articles, newspaper articles) to end 2018, notably those relating to the expulsion of one Governing Board member. MAIN FINDINGS: Both narratives include strong moral claims about the science of systematic review and the governance of scientific organizations. The expelled individual and his supporters defined good systematic reviews in terms of a particular kind of methodological rigour and elimination of bias, and good governance largely in terms of measures to achieve independence from industry influence. Most of Cochrane's Governing Board and their sympathizers evaluated systematic reviews according to a broader range of criteria, incorporating factors such as attention to relationships among reviewers and reflexivity and dialogue around scientific and other judgements. They viewed governance partly in terms of accountability to an external advisory group. Power-knowledge alignments in Cochrane have emerged from, and contributed to, a particular system of meaning which is now undergoing evolution and challenge. CONCLUSION: Polarizing Cochrane's "crisis" into two narratives, only one of which is true, is less fruitful than viewing it in terms of a duality consisting of tensions between the two positions, each of which has some validity. Having framed the conflict as primarily philosophical and political rather than methodological and procedural, we suggest how Cochrane and its supporters and critics might harness their tensions productively.
Asunto(s)
Emprendimiento/normas , Medicina Basada en la Evidencia , Consejo Directivo/ética , Bibliotecas Médicas , Evaluación de Resultado en la Atención de Salud , Calidad de la Atención de Salud , Nivel de Atención/ética , Complicidad , Medicina Basada en la Evidencia/ética , Medicina Basada en la Evidencia/métodos , Medicina Basada en la Evidencia/normas , Humanos , Servicios de Información/normas , Agencias Internacionales/organización & administración , Agencias Internacionales/normas , Bibliotecas Médicas/organización & administración , Bibliotecas Médicas/normas , Evaluación de Resultado en la Atención de Salud/ética , Evaluación de Resultado en la Atención de Salud/métodos , Evaluación de Resultado en la Atención de Salud/normas , Planificación de Atención al Paciente , Filosofía Médica , Revisiones Sistemáticas como AsuntoRESUMEN
BACKGROUND: Health care organizations can be very complex, and are often the setting for crisis situations. In recent years, Canadian health care organizations have faced large-scale systemic medical errors, a nation-wide generic injectable drug shortage, iatrogenic infectious disease outbreaks, and myriad other crises. These situations often have an ethical component that ethics consultants may be able to address. Organizational leaders such as health care managers and governing boards have responsibilities to oversee and direct the response to crisis situations. This study investigates the nature and degree of involvement of Canadian ethics consultants in such situations. METHODS: This qualitative study used semi-structured interviews with Canadian ethics consultants to investigate the nature of their interactions with upper-level managers and governing board members in health care organizations, particularly in times of organizational crisis. We used a purposive sampling technique to identify and recruit ethics consultants throughout Canada. RESULTS: We found variability in the interactions between ethics consultants and upper-level managers and governing boards. Some ethics consultants we interviewed did not participate in managing organizational crisis situations. Most ethics consultants reported that they had assisted in the management of some crises and that their participation was usually initiated by managers. Some ethics consultants reported the ability to bring issues to the attention of upper-level managers and indirectly to their governing boards. The interactions between managers and ethics consultants were characterized by varying degrees of collegiality. Ethics consultants reported participating in or chairing working groups, participating in incident management teams, and developing decision-making frameworks. CONCLUSIONS: Canadian ethics consultants tend to believe that they have valuable skills to offer in the management of organizational crisis situations. Most of the ethics consultants we interviewed believed that they play an important role in this regard.
Asunto(s)
Bioética , Consultores , Urgencias Médicas , Eticistas , Consultoría Ética , Consejo Directivo , Administración de los Servicios de Salud , Canadá , Toma de Decisiones , Comités de Ética , Consejo Directivo/ética , Administración de los Servicios de Salud/ética , Humanos , Relaciones Interprofesionales , Organizaciones/ética , Investigación CualitativaAsunto(s)
Centros Médicos Académicos/ética , Centros Médicos Académicos/organización & administración , Conflicto de Intereses , Industria Farmacéutica/economía , Consejo Directivo/ética , Personal Administrativo/economía , Personal Administrativo/ética , Comercio , Industria Farmacéutica/ética , Consejo Directivo/economía , Humanos , Liderazgo , Salarios y Beneficios , Estados UnidosAsunto(s)
Consejo Directivo/ética , Relaciones Médico-Paciente/ética , Medicina Estatal/normas , Comités Consultivos/ética , Comités Consultivos/organización & administración , Conflicto de Intereses , Toma de Decisiones en la Organización , Consejo Directivo/organización & administración , Humanos , Derivación y Consulta/ética , Derivación y Consulta/organización & administración , Medicina Estatal/ética , Medicina Estatal/organización & administración , Reino UnidoAsunto(s)
Conflicto de Intereses , Comercialización de los Servicios de Salud/ética , Informática Médica , Consejo Directivo/ética , Consejo Directivo/organización & administración , Humanos , Comercialización de los Servicios de Salud/economía , Comercialización de los Servicios de Salud/organización & administración , Informática Médica/ética , Informática Médica/organización & administración , Programas Informáticos/economía , Programas Informáticos/normas , Recursos HumanosRESUMEN
The board's compliance oversight responsibility starts with engaged, educated trustees. Learn the basics here.